APOE and atherosclerosis: Attempts to therapeutically target ICAM-1 to abrogate atherosclerosis in vivo have been successful in animal models; for example, ICAM-1 deficiency and anti-ICAM-1 antibody treatment protects against atherosclerosis in ApoE-deficient mice [34,46].